138 related articles for article (PubMed ID: 38574862)
1. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
J Thromb Haemost; 2024 Apr; ():. PubMed ID: 38574862
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
medRxiv; 2023 Oct; ():. PubMed ID: 37905148
[TBL] [Abstract][Full Text] [Related]
3. Circulating Extracellular Vesicle Tissue Factor Activity During Orthohantavirus Infection Is Associated With Intravascular Coagulation.
Schmedes CM; Grover SP; Hisada YM; Goeijenbier M; Hultdin J; Nilsson S; Thunberg T; Ahlm C; Mackman N; Fors Connolly AM
J Infect Dis; 2020 Sep; 222(8):1392-1399. PubMed ID: 31722433
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality.
Poh C; Brunson A; Keegan T; Wun T; Mahajan A
TH Open; 2020 Oct; 4(4):e309-e317. PubMed ID: 33134806
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated hemostasis in acute promyelocytic leukemia.
Hisada Y
Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
[TBL] [Abstract][Full Text] [Related]
7. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
8. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
Nguyen D; Kantarjian HM; Short NJ; Qiao W; Ning J; Cuglievan B; Daver NG; DiNardo CD; Jabbour EJ; Kadia TM; Borthakur G; Garcia-Manero G; Konopleva MY; Andreeff M; Ravandi-Kashani F; Sasaki K; Issa GC
Cancer; 2023 Jun; 129(12):1856-1865. PubMed ID: 36892949
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
[TBL] [Abstract][Full Text] [Related]
10. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
11. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
[TBL] [Abstract][Full Text] [Related]
12. Assessment of fibrinolytic markers in patients with deep vein thrombosis.
Sharma S; Uppal V; Senee HK; Ahluwalia J; Das R; Varma N; Malhotra P; Kumar N
Blood Coagul Fibrinolysis; 2022 Mar; 33(2):113-118. PubMed ID: 35140191
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
Hisada Y; Kawano T; Archibald SJ; Welch JS; Reeves BN; Mackman N
Blood Adv; 2023 Sep; 7(18):5458-5469. PubMed ID: 37450381
[TBL] [Abstract][Full Text] [Related]
14. The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
[TBL] [Abstract][Full Text] [Related]
15. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the coagulopathies associated with COVID-19 and sepsis.
Campbell RA; Hisada Y; Denorme F; Grover SP; Bouck EG; Middleton EA; Wolberg AS; Rondina MT; Mackman N
Res Pract Thromb Haemost; 2021 May; 5(4):e12525. PubMed ID: 34027292
[TBL] [Abstract][Full Text] [Related]
18. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
19. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.
Søgaard KK; Adelborg K; Darvalics B; Horváth-Puhó E; Beyer-Westendorf J; Ageno W; Sørensen HT
Lancet Haematol; 2018 Oct; 5(10):e441-e449. PubMed ID: 30201587
[TBL] [Abstract][Full Text] [Related]
20. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
Ten Cate H; Leader A
Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
